FDA WARNING_LETTER - OCLO LLC/OCLO Nanotechnology Science - April 15, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On April 15, 2021, the FDA and FTC reviewed the website https://dioxidodecloro.us, social media at https://facebook.com/Hallandale.Beach.2018/, and eCrater storefront (OCLO) operated by 220 SW 9th Ave, #506 Hallandale, FL 33009. The firm was found to be selling chlorine dioxide products, including "OCLO 3000," with claims to mitigate, prevent, treat, diagnose, or cure COVID-19.
These products are deemed unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)). Examples of violative claims include "This solution can be used to combat a large number of viral infections including COVID-19" and "The chlorine dioxide is effective for the COVID19 treatment."
The FDA requires immediate cessation of sales of these unapproved and unauthorized COVID-19 related products. The firm must email
ID · c4616695-53b3-49a5-be9b-a75ab6b5b50a
Full citation text and observation details available on the Dashboard.